164 related articles for article (PubMed ID: 27283119)
1. Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.
Bonomi A; Steimberg N; Benetti A; Berenzi A; Alessandri G; Pascucci L; Boniotti J; Coccè V; Sordi V; Pessina A; Mazzoleni G
Hematol Oncol; 2017 Dec; 35(4):693-702. PubMed ID: 27283119
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A
Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
[TBL] [Abstract][Full Text] [Related]
4. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
Xu X; Yang J; Tang Y; Li J; Zhu Y; Lu H; Fei X
Int J Clin Exp Pathol; 2014; 7(10):6705-15. PubMed ID: 25400750
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.
Petrella F; Coccè V; Masia C; Milani M; Salè EO; Alessandri G; Parati E; Sisto F; Pentimalli F; Brini AT; Pessina A; Spaggiari L
Biomed Pharmacother; 2017 Mar; 87():755-758. PubMed ID: 28153512
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
[TBL] [Abstract][Full Text] [Related]
7. Anti-cancer effects of Staphylococcal Enterotoxin type B on U266 cells co-cultured with Mesenchymal Stem Cells.
Ejtehadifar M; Halabian R; Fooladi AAI; Ghazavi A; Mosayebi G
Microb Pathog; 2017 Dec; 113():438-444. PubMed ID: 29170042
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
[TBL] [Abstract][Full Text] [Related]
9. An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma.
Kanehira M; Fujiwara T; Nakajima S; Okitsu Y; Onishi Y; Fukuhara N; Ichinohasama R; Okada Y; Harigae H
Stem Cells; 2017 Mar; 35(3):739-753. PubMed ID: 27641212
[TBL] [Abstract][Full Text] [Related]
10. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
[TBL] [Abstract][Full Text] [Related]
11. Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel.
Pessina A; Coccè V; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Navone S; Marfia G; Parati E; Alessandri G
Anticancer Agents Med Chem; 2013 Mar; 13(3):523-30. PubMed ID: 22931415
[TBL] [Abstract][Full Text] [Related]
12. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
[TBL] [Abstract][Full Text] [Related]
13. A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells.
Misund K; Baranowska KA; Holien T; Rampa C; Klein DC; Børset M; Waage A; Sundan A
J Biomol Screen; 2013 Jul; 18(6):637-46. PubMed ID: 23446700
[TBL] [Abstract][Full Text] [Related]
14. Liquid Overlay and Collagen-Based Three-Dimensional Models for
Ilic J; Koelbl C; Simon F; Wußmann M; Ebert R; Trivanovic D; Herrmann M
Tissue Eng Part C Methods; 2024 May; 30(5):193-205. PubMed ID: 38545771
[TBL] [Abstract][Full Text] [Related]
15. A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression.
Ciavarella S; Caselli A; Tamma AV; Savonarola A; Loverro G; Paganelli R; Tucci M; Silvestris F
Stem Cells Dev; 2015 Jun; 24(12):1457-70. PubMed ID: 25758779
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.
Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L
Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway.
Zhao P; Chen Y; Yue Z; Yuan Y; Wang X
Leuk Res; 2017 Jun; 57():20-26. PubMed ID: 28273548
[TBL] [Abstract][Full Text] [Related]
18. Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma.
Coccè V; Farronato D; Brini AT; Masia C; Giannì AB; Piovani G; Sisto F; Alessandri G; Angiero F; Pessina A
Sci Rep; 2017 Aug; 7(1):9376. PubMed ID: 28839168
[TBL] [Abstract][Full Text] [Related]
19. Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity.
Özcan S; Alessio N; Acar MB; Toprak G; Gönen ZB; Peluso G; Galderisi U
Oncotarget; 2015 Nov; 6(37):39482-92. PubMed ID: 26498687
[TBL] [Abstract][Full Text] [Related]
20. A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications.
Jakubikova J; Cholujova D; Hideshima T; Gronesova P; Soltysova A; Harada T; Joo J; Kong SY; Szalat RE; Richardson PG; Munshi NC; Dorfman DM; Anderson KC
Oncotarget; 2016 Nov; 7(47):77326-77341. PubMed ID: 27764795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
